Redmond A - Search Results

1

Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A.

Redmond A, Moran E, Clynes M. Redmond A, et al. Eur J Cancer. 1993;29A(8):1078-81. doi: 10.1016/s0959-8049(05)80291-6. Eur J Cancer. 1993. PMID: 8100138

2

Preliminary studies of a monoclonal antibody raised to the over expressed plasma membrane associated glycoprotein of a multidrug resistant cell line.

Moran E, Redmond A, Clynes M. Moran E, et al. Among authors: redmond a. Biochem Soc Trans. 1992 Feb;20(1):58S. doi: 10.1042/bst020058s. Biochem Soc Trans. 1992. PMID: 1353037 No abstract available.

3

Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.

Clynes M, Redmond A, Moran E, Gilvarry U. Clynes M, et al. Among authors: redmond a. Cytotechnology. 1992;10(1):75-89. doi: 10.1007/BF00376102. Cytotechnology. 1992. PMID: 1369413

4

Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.

Redmond A, Law E, Gilvarry U, Clynes M. Redmond A, et al. Cell Biol Toxicol. 1990 Jul;6(3):293-302. doi: 10.1007/BF02443804. Cell Biol Toxicol. 1990. PMID: 2253054

5

Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.

Heenan M, Kavanagh K, Redmond A, Maher M, Dolan E, O'Neill P, Moriarty M, Clynes M. Heenan M, et al. Among authors: redmond a. Cytotechnology. 1996;19(3):237-42. doi: 10.1007/BF00744218. Cytotechnology. 1996. PMID: 8862012

6

Analysis of the mechanism of resistance of 7 novel MDR variants.

Redmond A, Moran E, Clynes M. Redmond A, et al. Biochem Soc Trans. 1992 Feb;20(1):57S. doi: 10.1042/bst020057s. Biochem Soc Trans. 1992. PMID: 1353036 No abstract available.

7

Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.

Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, Hill AD, Young LS. Redmond AM, et al. Clin Cancer Res. 2009 Mar 15;15(6):2098-106. doi: 10.1158/1078-0432.CCR-08-1649. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276281

8

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.

Browne AL, Charmsaz S, Varešlija D, Fagan A, Cosgrove N, Cocchiglia S, Purcell S, Ward E, Bane F, Hudson L, Hill AD, Carroll JS, Redmond AM, Young LS. Browne AL, et al. Among authors: redmond am. Oncogene. 2018 Apr;37(15):2008-2021. doi: 10.1038/s41388-017-0042-x. Epub 2018 Jan 25. Oncogene. 2018. PMID: 29367763 Free PMC article.

9

Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer.

Al-azawi D, Ilroy MM, Kelly G, Redmond AM, Bane FT, Cocchiglia S, Hill AD, Young LS. Al-azawi D, et al. Among authors: redmond am. Oncogene. 2008 May 8;27(21):3021-31. doi: 10.1038/sj.onc.1210964. Epub 2007 Dec 3. Oncogene. 2008. PMID: 18059336

10

Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors.

Varešlija D, McBryan J, Fagan A, Redmond AM, Hao Y, Sims AH, Turnbull A, Dixon JM, Ó Gaora P, Hudson L, Purcell S, Hill AD, Young LS. Varešlija D, et al. Among authors: redmond am. Clin Cancer Res. 2016 Jun 1;22(11):2765-77. doi: 10.1158/1078-0432.CCR-15-1583. Epub 2016 Jan 13. Clin Cancer Res. 2016. PMID: 26763249 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters